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SUPPORTING INFORMATION
EXPERIMENTAL METHODS
Fusion gene construction
Light-chain Ft fusion constructs were generated using standard molecular cloning
techniques.  Original genes encoding human Ft were kindly supplied by Paulo Arosio;
genes encoding rat CREB and mouse CBP were obtained from Michael Greenberg.  KID-
LF encodes amino acids 88-160 of CREB, followed by the spacer GTSSEFM, and LF.
KIX-LF encodes amino acids 574-686 of CBP, followed by the same spacer and LF.
FLAG-LF encodes the amino acid sequence MDYKDHDGDYKDHDIDYKDDDDK
(3xFLAG, Sigma-Aldrich, St. Louis, MO) in place of KID or KIX.  All three LF fusion
constructs, along with unmodified LF and HF, were cloned into the pCMV-Sport vector
(Invitrogen, Carlsbad, CA) for expression in mammalian cells under the human
cytomegalovirus promoter.
Ft nanoparticle expression and purification
Ft nanoparticles were expressed in suspension-cultured HEK-293 cells using the
FreeStyle 293 system (Invitrogen), in accordance with manufacturer instructions.
Plasmids encoding HF, LF, FLAG-LF and either KID-LF or KIX-LF were mixed and
transfected into cells at predetermined ratios (by DNA mass), in a method used
commonly for expression of other multi-subunit proteins in mammalian cells (e.g. ion
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channels).  For a 60% functional group composition, the plasmid mixture contained 60%
KID-LF or KIX-LF, 20% FLAG-LF, 10% HF and 10% LF.  Lower functional group
compositions were compensated by unmodified LF.  Assuming quadrinomial statistics
(four possible constructs at each monomer position in Ft), and that incorporation of Ft
constructs is proportional to the transfected dose of the corresponding plasmid, a
minimum of 84% of expressed FtN particles was expected to contain one or more of each
of the four relevant constructs.  Four days after transfection, cells were harvested and
lysed in lysis buffer (50 mM Tris-HCl, 150 mM NaCl, 1 mM EDTA, 1% Triton X-100,
pH 7.4; 6 mL per pellet generated from a 50 mL culture) supplemented with a protease
inhibitor cocktail (Halt, Pierce, Rockford, IL).  Cleared lysates were supplemented
overnight with 2 mM ferrous ammonium sulfate (Sigma-Aldrich) at 4 °C.  Anti-FLAG
agarose (EZview, Sigma-Aldrich) was added for an additional 2 hours.  After washing
with wash buffer (50 mM Tris-HCl, 150 mM NaCl, pH 7.4), the nanoparticles were
eluted with 0.1 M glycine at pH 3.5, then quenched with 10X wash buffer.  Prior to
subsequent handling, nanoparticles were concentrated using centrifugal filter units and
buffer was exchanged to the assay buffer (10 mM HEPES, 150 mM NaCl, pH 7.4) using
size-exclusion chromatography.  Particle concentration was estimated by absorbance at
280 nm, as calibrated by an enzyme-linked immunosorbant assay (ELISA) for Ft (Leinco,
St. Louis, MO).  Protein expression level was quantified by comparing ELISA results to a
measurement of total cellular protein in cell lysates, obtained using the bicinchoninic acid
assay (Pierce, Rockford, IL).  FtN concentrations are given on a per-nanoparticle basis.
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Transmission electron microscopy and measurement of iron content
Samples were sonicated for five minutes in a water-bath sonicator (Cole-Parmer,
Vernon Hills, IL).  5 µl of the sonicated sample was adsorbed to a formvar/carbon coated
grid (Ernest F. Fullam, Latham, NY)  for one minute.  Excess liquid was removed from
the grid with Whatman #1 filter paper.  Grids were examined using a Tecnai G2 Spirit
BioTWIN transmission electron microscope (FEI, Hillsboro, OR). Nanoparticle iron
content was estimated using a ferrozine-based spectroscopic assay.  Protein shells were
denatured in sulfuric acid and free iron reduced using thiglycolic acid.  Excess ferrozine
was added, and iron concentration was estimated using an extinction coefficient of 2.79 x
104 M-1cm-1.
Phosphorylation and dephosphorylation
Phosphorylation was carried out by the addition of the recombinant catalytic
subunit of protein kinase A (PKA, Promega, Madison, WI) and 1 mM ATP (EMD
Chemicals, San Diego, CA).  For pre-phosphorylation, ~50 units of PKA were used per
pmol of Ft.  In DLS and MRI experiments, PKA was added directly from its original
stock solution.  To inhibit PKA activity, we used a peptide PKA inhibitor (Promega).
Dephosphorylation was accomplished using lambda protein phosphatase (λPPase, New
England Biolabs, Ipswich, MA), which was diluted in assay buffer and concentrated ~10-
fold relative to its stock solution. Protein phosphorylation states were assayed by
electrophoresis on 15% SDS-PAGE gels (BioRad, Hercules, CA) and staining using the
Pro-Q Diamond phosphoprotein staining kit (Invitrogen).  In gel images shown here,
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lanes have been rearranged digitally to align them in the order of data presented in
accompanying figures.
Dynamic light scattering
DLS measurements were performed using a DynaPro DLS system (Wyatt
Technology, Santa Barbara, CA) at 25 °C.  For each sample (20 µL), a single intensity-
weighted value was used to characterize the relative size of clusters in the specimen.
This value was an average of 60 measurements acquired over one minute.
Magnetic resonance imaging
Samples (45 µL) were arrayed into microtiter plates and placed in a 40 cm bore
Bruker (Billerica, MA) Avance 4.7 T MRI scanner, equipped with a 10 cm inner
diameter birdcage resonator radiofrequency coil and 26 G/cm triple axis gradients.
Unused wells of the microtiter plates were filled with phosphate buffered saline, and
imaging was performed on a 1.63 mm slice through the sample. A T2-weighted spin echo
pulse sequence with multiecho acquisition was used; repetition time (TR) was 4 s, and TE
ranged from 30 to 900 ms, in 30 ms increments.  Each acquisition lasted 8.5 minutes.
Data matrices of 512 x 128 points were acquired and zero-filled to 2048 x 1024 points,
where the second dimension corresponds to the phase encoding direction. Images were
reconstructed and analyzed using custom routines running in Matlab.  Relaxivities
reported here were calculated by exponential fitting to the image data, and are given on a
per-nanoparticle basis.  Contrast was linearly adjusted to produce MRI images presented
in the figures.
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AMINO ACID SEQUENCES OF FT FUSION CONSTRUCTS
Functional domains are highlighted in blue, linkers are highlighted in orange, and LF is in
black.
KID-LF:
MGSSCKDLKRLFSGTQISTIAESEDSQESVDSVTDSQKRREILSRRPSYR 50
KILNDLSSDAPGVPRIEEEKSEEETGTSSEFMSSQIRQNYSTDVEAAVNS 100
LVNLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAEEKREGYERLLKM 150
QNQRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGS 200
ARTDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFER 250
LTLKHD
KIX-LF:
MSTIPTAAPPSSTGVRKGWHEHVTQDLRSHLVHKLVQAIFPTPDPAALKD 50
RRMENLVAYAKKVEGDMYESANSRDEYYHLLAEKIYKIQKELEEKRRSRL 100
HKQGILGNQPALPAGTSSEFMSSQIRQNYSTDVEAAVNSLVNLYLQASYT 150
YLSLGFYFDRDDVALEGVSHFFRELAEEKREGYERLLKMQNQRGGRALFQ 200
DIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSARTDPHLCDFL 250
ETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFERLTLKHD
FLAG-LF:
MDYKDHDGDYKDHDIDYKDDDDKGTSSEFMSSQIRQNYSTDVEAAVNSLV 50
NLYLQASYTYLSLGFYFDRDDVALEGVSHFFRELAEEKREGYERLLKMQN 100
QRGGRALFQDIKKPAEDEWGKTPDAMKAAMALEKKLNQALLDLHALGSAR 150
TDPHLCDFLETHFLDEEVKLIKKMGDHLTNLHRLGGPEAGLGEYLFERLT 200
LKHD
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SUPPORTING RESULTS:  IMPACT OF THE CHOICE OF PURIFICATION
MOIETY ON STABILITY OF SELF-ASSEMBLED FTNS
Ferritin nanoparticles (FtNs) described in the main text were self-assembled from
co-transfected fusions of LF with KID, KIX, and FLAG, where the FLAG-LF construct
provided a means for purification of intact multifuntional FtNs.  We also tested
hexahistidine (6His) as a potential purification moiety.  A 6His-LF fusion construct was
generated with a GTSSEF linker and co-transfected into HEK293 cells together with
wild-type and functional subunits as described for FLAG-LF.  Self-assembled FtNs were
then purified over a Ni-NTA resin (Qiagen).  From cells transfected with plasmid
mixtures containing 60% KID-LF DNA, KID-functionalized FtNs were obtained as
expected.  Cells transfected with mixtures containing 60% KIX-LF DNA yielded FtNs
displaying few or no KIX groups, however (Supplementary Figure 1).  When transfection
mixtures contained FLAG-LF instead of 6His-LF, both KID-FtNs and KIX-FtNs
expressed and behaved as expected, as described in the main text.  The favorable
behavior of KIX-FtN constructs containing FLAG-LF vs. 6His-LF may have been due to
the greater negative charge, hydrophilicy, or bulkiness of FLAG compared with 6His.
These results highlight the engineering value of being able to easily substitute
functionalites in self-assembled FtNs.
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SUPPLEMENTARY FIGURE CAPTIONS
Supplementary Figure 1.  Transmission electron micrographs showing similar core
sizes for KID-FtNs (left), KIX-FtNs (middle) and horse spleen ferritin (HSF, right).
Scale bar 100 nm.  Arrowheads identify several particles in the FtN samples, where
individual molecules are more sparsely distributed than in the HSF sample.
Supplementary Figure 2. Coomassie stained SDS-PAGE gel showing the composition
of FtNs purified via co-expressed 6His-LF. Transfections included (by DNA amounts)
10% each of HF and LF, 20% 6His-LF and 60% of either KID-LF or KIX-LF. Wild type
Ft subunits appear on the gel around 20kDa. 6His-LF is the next band of higher
molecular weight. KID-LF and KIX-LF appear between 25kDa and 37kDa.
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Supplementary Figure 1
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Supplementary Figure 2
